1. Home
  2. MRNA vs AIT Comparison

MRNA vs AIT Comparison

Compare MRNA & AIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • AIT
  • Stock Information
  • Founded
  • MRNA 2010
  • AIT 1923
  • Country
  • MRNA United States
  • AIT United States
  • Employees
  • MRNA N/A
  • AIT N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • AIT Industrial Machinery/Components
  • Sector
  • MRNA Health Care
  • AIT Industrials
  • Exchange
  • MRNA Nasdaq
  • AIT Nasdaq
  • Market Cap
  • MRNA 10.9B
  • AIT 9.9B
  • IPO Year
  • MRNA 2018
  • AIT N/A
  • Fundamental
  • Price
  • MRNA $25.87
  • AIT $262.35
  • Analyst Decision
  • MRNA Hold
  • AIT Buy
  • Analyst Count
  • MRNA 19
  • AIT 8
  • Target Price
  • MRNA $43.50
  • AIT $287.86
  • AVG Volume (30 Days)
  • MRNA 12.2M
  • AIT 193.0K
  • Earning Date
  • MRNA 11-06-2025
  • AIT 10-23-2025
  • Dividend Yield
  • MRNA N/A
  • AIT 0.71%
  • EPS Growth
  • MRNA N/A
  • AIT 2.95
  • EPS
  • MRNA N/A
  • AIT 10.12
  • Revenue
  • MRNA $3,078,000,000.00
  • AIT $4,563,424,000.00
  • Revenue This Year
  • MRNA N/A
  • AIT $7.29
  • Revenue Next Year
  • MRNA $10.17
  • AIT $5.35
  • P/E Ratio
  • MRNA N/A
  • AIT $25.71
  • Revenue Growth
  • MRNA N/A
  • AIT 1.88
  • 52 Week Low
  • MRNA $23.15
  • AIT $199.96
  • 52 Week High
  • MRNA $75.37
  • AIT $282.98
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 51.44
  • AIT 48.03
  • Support Level
  • MRNA $23.18
  • AIT $258.00
  • Resistance Level
  • MRNA $25.90
  • AIT $266.60
  • Average True Range (ATR)
  • MRNA 1.16
  • AIT 5.94
  • MACD
  • MRNA 0.27
  • AIT -0.69
  • Stochastic Oscillator
  • MRNA 95.05
  • AIT 30.93

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About AIT Applied Industrial Technologies Inc.

Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.

Share on Social Networks: